FindTrial
Sign In

Biomarkers associated with early acute lung injury after liver transplantation in children

Biomarkers associated with early acute lung injury after liver transplantation in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059722
Enrollment
Unknown
Registered
2022-05-09
Start date
2022-06-20
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver transplantation

Interventions

Group 1 :
Group 2:

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 15 Years

Inclusion criteria

Inclusion criteria: 1. The anesthesia classification (ASA classification) is II-III; 2. The age of the patient is 0-15 years old; 3. Cardiac function grade I-II; 4. Diagnosed as children with biliary atresia; 5. No heart, lung, brain and other coexisting diseases before operation.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete medical records such as diagnosis and treatment; 2. Patients with liver cancer and other diseases; 3. Allergic constitution; 4. Unable to participate in the research; 5. Quit the researcher halfway.

Design outcomes

Primary

MeasureTime frame
miRNA-122;miRNA-21;S100 calcium-binding protein A8/A9 complex, S100A8/A9;—

Countries

China

Contacts

Public ContactWenli Yu

Tianjin First Central Hospital

yzxyuwenli@163.com+86 13920098326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026